Long noncoding TUG1 promotes angiogenesis of HUVECs in PE via regulating the miR-29a-3p/VEGFA and Ang2/Tie2 pathways-Reference-Cited by-同舟云学术

Long noncoding TUG1 promotes angiogenesis of HUVECs in PE via regulating the miR-29a-3p/VEGFA and Ang2/Tie2 pathways

Published:2022-01 Issue: Volume:139 Page:104231
ISSN:0026-2862
Container-title:Microvascular Research
language:en
Short-container-title:Microvascular Research

Author:

Liu Zhao,Guo Ning,Zhang Xiu-Jun

Funder

Central South University

Xiangya Hospital, Central South University

Publisher

Elsevier BV

Subject

Cell Biology,Cardiology and Cardiovascular Medicine,Biochemistry

Reference46 articles.

1. Evaluation of placental VEGFA mRNA expression in preeclampsia: a case control study;Agarwal;J. Obstet. Gynaecol. India,2019

2. Expression levels of maternal plasma microRNAs in preeclamptic pregnancies;Akgor;J. Obstet. Gynaecol.,2021

3. Pericytes contribute to dysfunction in a human 3D model of placental microvasculature through VEGF-ang-Tie2 signaling;Haase;Adv. Sci. (Weinh.),2019

4. LncRNA TUG1 promotes growth and metastasis of cholangiocarcinoma cells by inhibiting miR-29a;Hao;Cancer Manag. Res.,2020

5. MicroRNAs: small molecules with a large impact on pre-eclampsia;Hemmatzadeh;J. Cell. Physiol.,2020

Cited by 13 articles. 订阅此论文施引文献订阅此论文施引文献，注册后可以免费订阅5篇论文的施引文献，订阅后可以查看论文全部施引文献

1. Serum lncRNAs TUG1, H19, and NEAT1 and their target miR-29b/SLC3A1 axis as possible biomarkers of preeclampsia: Potential clinical insights;Non-coding RNA Research;2024-12

2. MicroRNA-195-5p Attenuates Pregnancy-Induced Hypertension by Inhibiting Oxidative Stress via OTX1/MAPK Signaling Pathway;Biochemical Genetics;2024-01-04

3. Huc-MSC-derived exosomal miR-144 alleviates inflammation in LPS-induced preeclampsia-like pregnant rats via the FosB/Flt-1 pathway;Heliyon;2024-01

4. Expression profile of LncRNA ANRIL, miR-186, miR-181a, and MTMR-3 in patients with preeclampsia;Non-coding RNA Research;2023-12

5. microRNAs: critical targets for treating rheumatoid arthritis angiogenesis;Journal of Drug Targeting;2023-11-23